Клинико-лабораторные проявления криптококкового менингоэнцефалита у больных ВИЧ-инфекцией

Раъно Касимова; Хилола Марданова

doi:10.47689/2181-3663-vol1-iss1-pp9-13

Rano Kasimova Research Institute of Virology, Tashkent, Uzbekistan
Khilola Mardanova Research Institute of Virology, Tashkent, Uzbekistan

DOI

https://doi.org/10.47689/2181-3663-vol1-iss1-pp9-13

Keywords

cryptococcus , meningoencephalitis , HIV , clinical and laboratory parameters

Abstract

Study of clinical and laboratory manifestations of cryptococcal meningoencephalitis in 16 patients with HIV infection. Women accounted for 18.8% (3), men - 81.2% (13). The condition of the patients was regarded as severe and extremely severe in 12 (75%) patients. The severity of the condition was due to severe intoxication and cerebral symptoms, convulsions were observed in 6 (37.5%) patients, in 7 (43.7%) - dysfunction of the pelvic organs. Despite ongoing therapy in 12 (75%) patients, the disease ended in death within 1 month.

References

Волкова О.Е., Венгеров Ю.А., Сафонова А.П., Свистунова Т.С., Тишкевич О.А. Клинико-патогенетические особенности крипто-коккового менингоэнцефалита у больных ВИЧ-инфекцией. Эпидемиология и инфекционные болезни, 2014;19(4):25-29 [ in Russian].

Чарушина И.П., Зотова Н.В. Клинико-морфологическая характеристи-ка криптококкоза при ВИЧ-инфекции. Журнал инфектологии, 2012;4(4):65-70 [ in Russian].

Bongomin F., Gago S., Oladele R.O., Denning D.W. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision. J. Fungi. 2017;3:57. doi: 10.3390/jof3040057.

Day J.N., Chau T.T.H., Wolbers M., Mai P.P., Dung N.T., Mai N.H., Phu N.H., Nghia H.D., Phong N.D., Thai C.Q., et al. Combination Antifungal Therapy for Cryptococcal Meningitis. N. Engl. J. Med. 2013;368:1291–1302. doi: 10.1056/NEJMoa1110404.

Graybill JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000; 30:47.].

Murakawa GJ, Kerschmann R, Berger T. Cutaneous Cryptococcus infection and AIDS. Report of 12 cases and review of the literature. Arch Dermatol 1996; 132:545. Rex JH, Larsen RA, Dismukes WE, et al. Catastrophic visual loss due to Cryptococcus neoformans meningitis. Medicine (Baltimore) 1993; 72:207.

Park B.J., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Chiller T.A.M. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. Aids. 2009;23:525–530. doi: 10.1097/QAD.0b013e328322ffac.

Rajasingham R., Rachel M.S., Benjamin J.P., Joseph N.J., Nelesh P.G., Tom M.C., David W.D., Angela L., David R.B. Global Burden of Disease of HIV-Associated Cryptococcal Meningitis: An Updated Analysis. Lancet Infect. Dis. 2017;3099:1–9. doi: 10.1016/S1473-3099(17)30243-8.

Downloads

PDF (Русский)

126 115

Published

2022-12-15

How to Cite

Kasimova , R. and Mardanova , K. 2022. Clinical and laboratory manifestations of cryptococcal meningoencephalitis in patients with HIV infection. Preventive Medicine and Health. 1, 1 (Dec. 2022), 9–13. DOI:https://doi.org/10.47689/2181-3663-vol1-iss1-pp9-13.